APA

Falcioni F., Ito K., Vidovic D., Belunis C., Campbell R., Berthel S. J., Bolin D. R., Gillespie P. B., Huby N., Olson G. L., Sarabu R., Guenot J., Madison V., Hammer J., Sinigaglia F., Steinmetz M. & Nagy Z. A. (19990715). Peptidomimetic compounds that inhibit antigen presentation by autoimmune disease-associated class II major histocompatibility molecules. : Nature biotechnology.

Chicago

Falcioni F, Ito K, Vidovic D, Belunis C, Campbell R, Berthel S J, Bolin D R, Gillespie P B, Huby N, Olson G L, Sarabu R, Guenot J, Madison V, Hammer J, Sinigaglia F, Steinmetz M and Nagy Z A. 19990715. Peptidomimetic compounds that inhibit antigen presentation by autoimmune disease-associated class II major histocompatibility molecules. : Nature biotechnology.

Harvard

Falcioni F., Ito K., Vidovic D., Belunis C., Campbell R., Berthel S. J., Bolin D. R., Gillespie P. B., Huby N., Olson G. L., Sarabu R., Guenot J., Madison V., Hammer J., Sinigaglia F., Steinmetz M. and Nagy Z. A. (19990715). Peptidomimetic compounds that inhibit antigen presentation by autoimmune disease-associated class II major histocompatibility molecules. : Nature biotechnology.

MLA

Falcioni F, Ito K, Vidovic D, Belunis C, Campbell R, Berthel S J, Bolin D R, Gillespie P B, Huby N, Olson G L, Sarabu R, Guenot J, Madison V, Hammer J, Sinigaglia F, Steinmetz M and Nagy Z A. Peptidomimetic compounds that inhibit antigen presentation by autoimmune disease-associated class II major histocompatibility molecules. : Nature biotechnology. 19990715.